Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent.
Med Hypotheses
; 143: 109858, 2020 Oct.
Article
em En
| MEDLINE
| ID: mdl-32516655
ABSTRACT
Coronavirus disease outbreak caused a severe public health burden all over the world. Salinomycin (SAL) is a broad-spectrum antibiotic that had drawn attention in selective targeting of cancer and viral infections. Recent drug screen identified SAL as a potent antiviral agent against SARS-CoV-2. In this hypothesis, we discuss the potential of pulmonary delivery of SAL using nanostructured lipid carriers (NLCs) against SARS-CoV-2.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Pneumonia Viral
/
Piranos
/
Portadores de Fármacos
/
Infecções por Coronavirus
/
Nanoestruturas
/
Lipídeos
Limite:
Humans
Idioma:
En
Revista:
Med Hypotheses
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Índia